Can you diagnose hair loss (Non-scarring alopecia)

Introduction: Many procedures are performed on the scalp, such as excision of pilar and sebaceous cysts, melanocytic nevi, and reduction surgery for scarring alopecia, among others. In hair transplants, telogen effluvium is often reported 3 months after surgery; however, hair loss usually happens much earlier, around second week after the procedure, not compatible with the time required for hair to enter telogen and exogenous phases in normal conditions. Case Reports: We report 3 cases of anagen hair loss 4 weeks after surgeries, with perilesional trichoscopy suggesting anagen effluvium, with typical signs such as black dots and exclamation hairs. Discussion: There are only a few reports about hair loss around operated areas. The cause of this postoperative anagen effluvium is probably a transient ischemia. Conclusion: The practical importance of this phenomenon is to properly orient patients because most of the hair will be lost, since 85% of them are anagens, and also will have spontaneous recovery in the next 3 months.

Download Full-text

Changes in the hair growth cycle in women with non-scarring alopecia

Vestnik dermatologii i venerologii ◽

10.25208/0042-4609-2018-94-5-39-49 ◽

2019 ◽

Vol 94 (5) ◽

pp. 39-49

Author(s):

A. A. Kubanov ◽

Y. A. Gallyamova ◽

O. A. Korableva

Keyword(s):

Growth Factors ◽

Growth Factor ◽

Hair Loss ◽

Reference Group ◽

Growth Cycle ◽

Punch Biopsy ◽

Androgenetic Alopecia ◽

Pharmacological Agents ◽

Scarring Alopecia ◽

Cycle Growth

One of the key elements in the pathophysiological process of androgenetic alopecia and telogen hair loss is the change of hair cycle. Growth factors controlling the development and cycle of the hair follicle have thus far been established. However, the role of growth factors in the pathogenesis of alopecia remains to be revealed.Objective.This study was aimed at investigating the expression of the VEGF, KGF, EGF and TGF-01 growth factors in women with androgenetic alopecia and telogen hair loss, as well as their role in the development of alopecia.Materials and methods. 60 female patients diagnosed with telogen hair loss (30 women) and androgenetic alopecia (30 women) were observed. In order to investigate the expression of the VEGF, KGF, EGF and TGF-01 growth factors, we conducted an immunofluorescent analysis of skin samples obtained by punch biopsy (4 mm) from the frontoparietal scalp area of patients with androgenetic alopecia and telogen hair loss. 15 samples obtained from healthy people were used as a reference group.Results.A change in the expression of the VEGF, KGF and TGF-01 growth factors in women with androgenetic alopecia and telogen hair loss was established in comparison with healthy individuals. A correlation was found between the expression of the growth factors under study, age (p ≤ 0.05), as well as the character and duration of the disease (p ≤ 0.05) in women with non-scarring alopecia. The expression of the growth factors is found to be dependent on the clinical form of alopecia (p < 0.001).Conclusion.The VEGF growth factor is established to have the most significant effect on the development of androgenetic alopecia in women, with the KGF, TGF-01 and EGF factors being less significant as the predictors of this disorder. The VEGF growth factor is shown to affect telogen hair loss to a greater extent compared to the EGF factor. Our study confirms differences in the pathogenesis of androgenetic alopecia and telogen hair loss in women. The findings suggest that the VEGF and KGF growth factors, as well as TGF-01 inhibitors may be used as potential pharmacological agents for treating patients suffering from androgenetic alopecia and telogen hair loss.

Download Full-text

Pseudopelade of Brock: clinical observation

RUDN Journal of Medicine ◽

10.22363/2313-0245-2020-24-4-368-372 ◽

2020 ◽

Vol 24 (4) ◽

pp. 368-372

Author(s):

S. K. Ryabov ◽

O. A. Mesnyankina

Keyword(s):

Histological Examination ◽

Rare Variant ◽

Hair Loss ◽

Clinical Observation ◽

Detailed Examination ◽

Close Attention ◽

Scarring Alopecia ◽

Skin Biopsies

The article presents clinical observation of a rare variant of scarring alopecia - pseudopelade Brock. The presented case demonstrates the important role of detailed examination and close attention to patients with long-term foci of hair loss in the absence of positive dynamics from the therapy, maintaining clinical alertness and conducting a broad differential diagnostic search to exclude rare dermatoses, and also confirms the need for histological examination of skin biopsies to verify the diagnosis.

Download Full-text

Use of trichoscopy for the diagnosis of alopecia areata coexisting with primary scarring alopecia in a female hair loss patient

The Journal of Dermatology ◽

10.1111/1346-8138.14841 ◽

2019 ◽

Vol 46 (5) ◽

pp. 418-421

Author(s):

Masahiro Fukuyama ◽

Manabu Ohyama

Keyword(s):

Hair Loss ◽

Alopecia Areata ◽

Scarring Alopecia

Download Full-text

Alopecias in lupus erythematosus

Lupus Science & Medicine ◽

10.1136/lupus-2018-000291 ◽

2018 ◽

Vol 5 (1) ◽

pp. e000291 ◽

Cited By ~ 12

Author(s):

Josef Symon Salgado Concha ◽

Victoria P Werth

Keyword(s):

Hair Loss ◽

Alopecia Areata ◽

Lupus Erythematosus ◽

Systemic Disease ◽

Classification Criteria ◽

Systemic Lupus ◽

Scarring Alopecia ◽

Histological Characteristics

Several patterns of hair loss can occur in lupus erythematosus (LE). Alopecias which show histological characteristics of LE are LE-specific, and include discoid LE (DLE), diffuse or patchy hair loss in acute LE, subacute cutaneous LE, and rarely tumid LE. Lupus hair in SLE is a poorly characterised entity and may be a form of telogen effluvium. Alopecia areata can coexist with LE and may mimic DLE. Non-lupus alopecias such as telogen effluvium and anagen effluvium have a myriad of causes which include disease flares, drugs and stress in the setting of LE. The latest validated Systemic Lupus International Collaborating Clinics classification criteria for SLE includes non-scarring alopecia as a criterion; therefore, recognising the aetiology of hair loss in the setting of LE is crucial in classifying a patient to have systemic disease.

Download Full-text

Role of Hair Transplantation in Scarring Alopecia—To Do or Not to Do

Indian Journal of Plastic Surgery ◽

10.1055/s-0041-1739246 ◽

2021 ◽

Author(s):

Sukhbir Singh ◽

Kumaresan Muthuvel

Keyword(s):

Early Diagnosis ◽

Disease Progression ◽

Hair Loss ◽

Treatment Process ◽

Treatment Protocol ◽

Aggressive Treatment ◽

Hair Transplantation ◽

Scarring Alopecia ◽

Hair Transplant

AbstractAlopecia in the scalp region leads to psychosocial embarrassment for an individual. Alopecia could be due to several reasons, including genetic, hormonal, traumatic and infections. Cicatricial alopecias (CAs) are considered as trichological emergency, since their progression is rapid and always results in permanent hair loss. The pathogenesis, disease progression and prognosis of CA are poorly understood, and the treatment process is still evolving. An early diagnosis must be established, and aggressive treatment protocol should be followed in the management of scarring alopecia. This article presents various aspects of CA and determines whether hair transplant (HT) should be done in this condition.

Download Full-text

Scarring Alopecia: The Attitudes, Knowledge and Referral Patterns of Hair Stylists and Barbers

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.2.4.2 ◽

2018 ◽

Vol 2 (4) ◽

pp. 214-218

Author(s):

Julia Accetta ◽

Aderonke Obayomi ◽

Rachel Evers-Meltzer ◽

Virginia Alldredge ◽

Andrea Murina

Keyword(s):

Hair Loss ◽

Signs And Symptoms ◽

Further Training ◽

Referral Patterns ◽

Additional Training ◽

Unique Position ◽

Scarring Alopecia ◽

Early Signs

Disorders of hair loss are commonly encountered by hair stylists, who are in a unique position to identify early signs and symptoms. The goals of this study were to assess hair stylists’ knowledge of and propensity to refer patients with scarring alopecias. One-hundred-eighteen stylists completed surveys to this effect. The majority of respondents (66.1%) stated that they had been asked by clients to evaluate for hair loss, whereas approximately half reported routinely referring clients with hair loss to a dermatologist. Although knowledge of alopecia varied, the vast majority indicated they would be willing to undergo further training in identifying hair loss disorders and would be willing to discuss this information with clients. These results demonstrate that hairdressers frequently interact with patients suffering from hair loss and that many are receptive to receiving additional training to ensure proper identification and prompt referral.

Download Full-text

TO STUDY AYURVEDIC MANAGEMENT OF ALOPECIA AREATA (INDRALUPTA)

National Journal of Research in Ayurved Science ◽

10.52482/ayurlog.v7i03.359 ◽

2019 ◽

Vol 7 (03) ◽

Author(s):

Sayali Sudesh Vora

Keyword(s):

T Cell ◽

Hair Loss ◽

Alopecia Areata ◽

Modern Medicine ◽

Immune Disorder ◽

Scarring Alopecia

Alopecia areata is a T cell driven auto immune disorder producing non scarring alopecia. The cause of this disease is unknown. It is also known as spot baldness.It causes hair loss of scalp, face and sometimes other areas of body. [1] The lifetime incidence of alopecia areata is 0.1% â€“ 0.2% of the population. More than half of affected patients are younger than 20 years. There is no predictable treatment in modern medicine. High and super potency corticosteroids are used orally, topically or intradermal injections. But mode of treatment is impractical in children According to Ayurveda, Indralupta is one of the type of khalitya .Ayurvedic texts in the context of khalitya explained is primarily predominant tridoshajanya vyadh

Download Full-text

Hair transplantation in androgenetic alopecia

10.25259/csdm_14_2021 ◽

2021 ◽

Vol 1 ◽

pp. 20

Author(s):

Kavish Chouhan ◽

Gillian Roga

Keyword(s):

Medical Therapy ◽

Hair Loss ◽

Androgenetic Alopecia ◽

Hair Transplantation ◽

Common Cause ◽

The Past ◽

Scarring Alopecia ◽

Male Pattern

Androgenetic alopecia is the most common cause of non-scarring alopecia in men. Even though the past couple of years have seen significant advancements in the management of patterned hair loss. Medical therapy as a standalone treatment remains unsatisfactory and surgical restoration of hair has found to be extremely gratifying as far as male pattern hair loss is concerned. In this article, we will review the latest developments in the field of hair transplantation undertaken in androgenetic alopecia.

Download Full-text